Trial intelligence / Profile preview

Metformin and Esomeprazole in Preterm Preeclampsia

NCT06359015Phase 4Terminated

Sponsor
ChristianaCare
Start
Feb 2021
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liquid metformin (Aspargo Labs), esomeprazole in preeclampsia, sponsored by ChristianaCare. Started Feb 2021; status: terminated.

02

Drugs

liquid metformin (Aspargo Labs)esomeprazole
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT06359015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06359015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call